|
1
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
|
4
|
Yamamoto C, Basaki Y, Kawahara A, et al:
Loss of PTEN expression by blocking nuclear translocation of EGR1
in gefitinib-resistant lung cancer cells harboring epidermal growth
factor receptor-activating mutations. Cancer Res. 70:8715–8725.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang A, Gao X, Zhang D, Zhang L and Lu H:
Expression and clinical significance of the Trop-2 gene in advanced
non-small cell lung carcinoma. Oncol Lett. 6:375–380.
2013.PubMed/NCBI
|
|
6
|
Gelsomino F, Rossi G and Tiseo M: Clinical
implications and future perspectives in testing non-small cell lung
cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene
rearrangements. J Thorac Dis. 7:220–223. 2015.PubMed/NCBI
|
|
7
|
Thomas A, Lee JH, Abdullaev Z, et al:
Characterization of fibroblast growth factor receptor 1 in
small-cell lung cancer. J Thorac Oncol. 9:567–571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calabrese G, Crescenzi C, Morizio E, Palka
G, Guerra E and Alberti S: Assignment of TACSTD1 (alias TROP1,
M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2
(alias TROP2, M1S1) to human chromosome 1p32 by n situ
hybridization. Cytogenet Cell Genet. 92:164–165. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taylor JT, Zeng XB, Pottle JE, et al:
Calcium signaling and T-type calcium channels in cancer cell
cycling. World J Gastroenterol. 14:4984–4991. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nelsen CJ, Kuriyama R, Hirsch B, et al:
Short term cyclin D1 overexpression induces centrosome
amplification, mitotic spindle abnormalities, and aneuploidy. J
Biol Chem. 280:768–776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cubas R, Zhang S, Li M, Chen C and Yao Q:
Trop2 expression contributes to tumor pathogenesis by activating
the ERK MAPK pathway. Mol Cancer. 9:2532010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang HF and Bo JJ: Trophoblastic cell
surface protein 2 and tumor. Guo Ji Zhong Liu Xue Za Zhi. 39:96–98.
2012.(In Chinese).
|
|
13
|
Ohmachi T, Tanaka F, Mimori K, Inoue H,
Yanaga K and Mori M: Clinical significance of TROP2 expression in
colorectal cancer. Clin Cancer Res. 12:3057–3063. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fong D, Spizzo G, Gostner JM, et al:
TROP2: A novel prognostic marker in squamous cell carcinoma of the
oral cavity. Mod Pathol. 21:186–191. 2008.PubMed/NCBI
|
|
15
|
Fong D, Moser P, Krammel C, et al: High
expression of TROP2 correlates with poor prognosis in pancreatic
cancer. Br J Cancer. 99:1290–1295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kobayashi H, Minami Y, Anami Y, Kondou Y,
Iijima T, Kano J, Morishita Y, Tsuta K, Hayashi S and Noguchi
MIASLC International Staging Committee: Expression of the GA733
gene family and its relationship to prognosis in pulmonary
adenocarcinoma. Virchows Arch. 457:69–76. 2010.
|
|
17
|
Pak MG, Shin DH, Lee CH and Lee MK:
Significance of EpCAM and TROP2 expression in non-small cell lung
cancer. World J Surg Oncol. 10:532012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu YP, Zhao YG, Zhu YB, Zhang GB and Huang
JA: Primary study of expression of TROP-2 in human pulmonary
adenocarcinoma and cell lines. Zhong Liu Fang Zhi Za Zhi.
20:342–346. 2013.(In Chinese).
|
|
19
|
Jiang AG, Lu HY, Zhang DG, Zhang LX and
Gao XY: Short hairpin RNA targeting AKT1 and PI3K/p85 suppresses
the proliferation and self renewal of lung cancer stem cells. Mol
Med Rep. 12:363–370. 2015.PubMed/NCBI
|
|
20
|
Shen YH, Godlewski J, Bronisz A, et al:
Significance of 14-3-3 self-dimerization for
phosphorylation-dependent target binding. Mol Biol Cell.
14:4721–4733. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tong XD, Liu HX, Zhao HR, et al: The role
of Smad4 and MAPK proteins in signal transduction pathway in
non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi. 28:741–745.
2006.(In Chinese). PubMed/NCBI
|
|
22
|
Lebeau A, Unholzer A, Amann G, et al:
EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell
proliferation and steroid hormone receptor status in ductal
carcinoma n situ of the breast. Breast Cancer Res Treat.
79:187–198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martin MD and Matrisian LM: The other side
of MMPs: Protective roles in tumor progression. Cancer Metastasis
Rev. 26:717–724. 2007. View Article : Google Scholar : PubMed/NCBI
|
